查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888686

感染疾病诊断剂市场规模、份额和趋势分析报告：按产品、治疗领域、技术、最终用途、地区和细分市场预测（2025-2033 年）

Diagnostic Reagents For Infectious Diseases Market Size, Share & Trends Analysis Report By Product, By Disease Area, By Technology, By End Use, By Region, and Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

感染疾病诊断剂市场摘要

2024年全球感染疾病诊断剂市场规模估计为34.7531亿美元，预计2033年将达到80.7907亿美元。

预计从 2025 年到 2033 年，该市场将以 9.30% 的复合年增长率成长。市场成长的主要驱动力是呼吸系统疾病和性行为感染感染 (STI) 的上升趋势。

呼吸系统疾病，例如流感、新冠肺炎、肺炎和结核病，在全球发病率最高。根据联合国儿童基金会2023年的报告，全球每年每10万名儿童中就有超过1,400例肺炎病例，即每71名儿童中就有1例。 2023年发病率最高的地区是南亚（每10万名儿童中有2500例）和西非及中非（每10万名儿童中有1620例）。

此外，根据世界卫生组织估计，全球约有1,080万人感染结核病，其中男性600万，女性360万，其他人口130万。因此，结核病发病率的上升刺激了对分子诊断和就地检验等先进诊断技术的强劲需求，从而推动了市场成长。此外，远端医疗服务的快速发展和家庭检测解决方案的广泛应用也进一步促进了市场扩张。

此外，全球意识的提高和政府支持的筛检计画正在促进早期发现和预防工作。 2025年5月出版的《世界卫生日誌》发表了一项关于1996年至2023年感染疾病疫情分布及其对健康影响的全球评估报告。世界卫生组织（世卫组织）已确定约30种优先病原体，包括猴痘、登革热和甲型流感病毒，这些病原体有可能引发全球公共卫生紧急事件。这份更新后的清单强调了应对这些高风险感染疾病的重要性，因为它们具有高传染性、高致病性以及缺乏疫苗或治疗方法等特征。随着气候变迁、森林砍伐和都市化进程加快等全球性问题加剧了这些疾病传播的风险，对感染疾病试剂的需求也不断增长。

此外，先进分子技术在发展中地区的普及在推动市场成长方面发挥关键作用。医疗基础设施投资的增加以及创新诊断工具取得途径的改善，使得感染疾病的快速、低成本和高精度检测成为可能。例如，2024年1月，荷兰凯杰公司（QIAGEN）在印度推出了QIAstat-Dx仪器的检测试剂盒和试剂，这些试剂盒和试剂旨在快速准确地诊断感染疾病。这些措施正在加速分子诊断技术在开发中地区的普及，从而显着促进市场成长。

此外，各国政府加大对病原体基因组监测的投入，推动了分子诊断相关感染疾病试剂的需求。 2024年2月，世界卫生组织宣布捐助者承诺提供400万美元，设立一项催化津贴基金，支持开展病原体基因组监测的组织。该基金将支持全球范围内的先导计画，尤其是在中低收入国家。随着各实验室实施这些先导计画，对分子诊断剂（包括PCR试剂盒、定序试剂和其他耗材）的需求日益增长。检测能力的提升确保了试剂更频繁、更常规的使用，从而创造了持续的需求，并增强了全球有效检测、预防和应对感染疾病疫情的能力。

目录

第一章感染疾病诊断剂市场：调查方法与范围

第二章：感染疾病诊断剂市场：执行摘要

  • 市场概览
  • 产品
  • 疾病领域概述
  • 技术概述
  • 最终用途概述
  • 竞争格局概述

第三章感染疾病诊断剂市场的变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 再次出现的感染疾病增加
    • 分子诊断技术的进展
  • 市场限制因素分析
    • 复杂的检验过程
    • 感染疾病诊断剂高成本
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章感染疾病诊断剂市场：按产品分類的估算与趋势分析

  • 感染疾病诊断剂市场：依产品分類的波动分析
  • 分子试剂
  • 免疫检测试剂
  • 快速检测试剂
  • 血清学试剂
  • 控制器和校准器
  • 其他试剂

第五章：感染疾病诊断剂市场：依疾病领域分類的估算与趋势分析

  • 感染疾病诊断剂市场：依疾病领域分析市场波动
  • 呼吸道感染疾病
  • 性行为感染疾病和热带疾病
  • 肠道感染疾病
  • 性行为感染感染（STI）
  • 其他感染疾病/高负担感染疾病

第六章：感染疾病诊断剂市场：依技术分類的估算与趋势分析

  • 感染疾病诊断剂市场：波动分析
  • 分子诊断
  • 免疫检测
  • 照护现场试剂
  • 多路復用平台

第七章感染疾病诊断剂市场：依最终用途分類的估算与趋势分析

  • 感染疾病诊断剂市场：依最终用途分類的差异分析
  • 医院和诊所
  • 诊断检查室
  • 即时侦测/分散式检查设施
  • 公共卫生机构与国家参考实验室
  • 学术和研究机构

第八章感染疾病诊断剂市场：按地区分類的业务分析

  • 区域市场概览
  • 北美洲
  • 欧洲
  • 亚太地区

竞争场景

  • 拉丁美洲
    • 2021-2033年拉丁美洲感染疾病诊断剂市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲感染疾病诊断剂市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合资
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • QIAGEN
    • bioMerieux
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
    • Thermo Fisher Scientific, Inc.
    • SD Biosensor
    • Mindray
    • Boditech Med Inc.
Product Code: GVR-4-68040-817-0

Diagnostic Reagents For Infectious Diseases Market Summary

The global diagnostic reagents for infectious diseases market size was estimated at USD 3,475.31 millionin 2024 and is projected to reach USD 8,079.07 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. The market is primarily driven by the increasing prevalence of respiratory diseases and sexually transmitted infections (STIs).

Respiratory diseases, including influenza, COVID-19, pneumonia, and tuberculosis, have the highest prevalence worldwide. The UNICEF 2023 report stated that, every year, there are over 1,400 cases of pneumonia per 100,000 children worldwide, or one case per 71 children, with the highest incidences occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000) in 2023.

Moreover, the WHO estimated 10.8 million people worldwide became ill with tuberculosis, including 6.0 million men, 3.6 million women, and 1.3 million. Therefore, the rising prevalence rate is driving strong demand for advanced diagnostic technologies such as molecular diagnostics and point-of-care testing, fueling market growth. In addition, the rapid expansion of telemedicine services and the growing adoption of home-based testing solutions are further contributing to the market's expansion.

Furthermore, rising global awareness and government-supported screening programs are encouraging early detection and prevention initiatives. The Journal of Global Health reported in May 2025 that the distribution and health impact of infectious disease outbreaks from 1996 to 2023 were globally assessed. The World Health Organization has identified approximately 30 priority pathogens, including monkeypox virus, dengue virus, and influenza A viruses, that could cause global public health emergencies. This updated list emphasizes the significance of focusing efforts on these high-risk infections due to their high transmissibility, virulence, and the scarcity of vaccines and treatment options. As global concerns such as climate change, deforestation, and growing urbanization increase the risk of these illnesses spreading, boosting the demand for infectious disease reagents.

Furthermore, the expansion of advanced molecular technologies in developing regions is playing a crucial role in driving market growth. Growing investments in healthcare infrastructure and increasing access to innovative diagnostic tools are enabling faster, cost-effective, and more accurate detection of infectious diseases. For instance, in January 2024, QIAGEN (Netherlands) launched testing panels for its QIAstat-Dx instruments, along with reagents, in India for rapid and accurate diagnosis of infectious diseases. Such initiatives are accelerating the adoption of molecular diagnostics in developing regions and significantly contributing to market growth.

Moreover, the increasing funding by governments to target pathogen genomic surveillance is boosting the demand for infectious disease reagents associated with molecular diagnostics. In February 2024, the WHO announced that donors had contributed USD 4 million to establish a catalytic grant fund for organizations working in pathogen genomic surveillance. The fund will support pilot projects worldwide, particularly in low- and middle-income countries. As laboratories implement these pilot projects, there is an increased need for molecular diagnostics reagents, including PCR kits, sequencing reagents, and other consumables. This expansion of testing capabilities ensures more frequent and routine use of reagents, creating sustained demand while enhancing global capacity to detect, prevent, and respond effectively to infectious disease outbreaks.

Global Diagnostic Reagents For Infectious Diseases Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global diagnostic reagents for infectious diseases market report based on product, disease area, technology, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Reagents
  • Immunoassay Reagents
  • Rapid Test Reagents
  • Serology Reagents
  • Controls and Calibrators
  • Other Reagents
  • Disease Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory Infections
  • Vector-Borne & Tropical Diseases
  • Enteric Infections
  • Sexually Transmitted Infections (STIs)
  • Other Emerging / High-Burden Infectious Diseases
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
  • Immunoassays
  • Point-of-Care Reagents
  • Multiplex Platforms
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Point-of-Care / Decentralized Testing Sites
  • Public Health Agencies & National Reference Labs
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Diagnostic Reagents for Infectious Diseases Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product
      • 1.1.1.2. Disease Area Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Diagnostic Reagents for Infectious Diseases Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product
  • 2.3. Disease Area Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Diagnostic Reagents for Infectious Diseases Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increase in re-emerging infectious diseases
    • 3.4.2. Advancements in molecular diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Complex validation processes
    • 3.5.2. High cost of infectious disease diagnostic reagents
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Diagnostic Reagents for Infectious Diseases Market: Product Estimates & Trend Analysis

  • 4.1. Diagnostic Reagents for Infectious Diseases Market: Product Movement Analysis
  • 4.2. Molecular Reagents
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay Reagents
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Rapid Test Reagents
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serology Reagents
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Controls and Calibrators
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Other Reagents
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Diagnostic Reagents for Infectious Diseases Market: Disease Area Estimates & Trend Analysis

  • 5.1. Diagnostic Reagents for Infectious Diseases Market: Disease Area Movement Analysis
  • 5.2. Respiratory Infections
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Vector-Borne & Tropical Diseases
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Enteric Infections
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Sexually Transmitted Infections (STIs)
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Emerging / High-Burden Infectious Diseases
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Diagnostic Reagents for Infectious Diseases Market: Technology Estimates & Trend Analysis

  • 6.1. Diagnostic Reagents for Infectious Diseases Market: End Use Movement Analysis
  • 6.2. Molecular Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Immunoassays
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Point-of-Care Reagents
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Multiplex Platforms
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Diagnostic Reagents for Infectious Diseases Market: End Use Estimates & Trend Analysis

  • 7.1. Diagnostic Reagents for Infectious Diseases Market: End Use Movement Analysis
  • 7.2. Hospitals & Clinics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Point-of-Care / Decentralized Testing Sites
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Public Health Agencies & National Reference Labs
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Diagnostic Reagents for Infectious Diseases Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Diagnostic Reagents for Infectious Diseases Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario

. Competitive Scenario

  • 8.5. Latin America
    • 8.5.1. Latin America Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. F. Hoffmann-La Roche Ltd
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Abbott
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. QIAGEN
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. bioMerieux
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Bio-Rad Laboratories, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Seegene Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Thermo Fisher Scientific, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. SD Biosensor
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Mindray
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Boditech Med Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Diagnostic Reagents for Infectious Diseases Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 6 Global Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 11 North America Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 15 U.S. Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 19 Canada Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 23 Mexico Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 28 Europe Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 32 UK Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 36 Germany Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 40 France Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 44 Italy Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 48 Spain Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Sweden Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 52 Sweden Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Norway Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 56 Norway Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 60 Denmark Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 69 Japan Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 73 China Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 China Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 77 India Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 India Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 81 Australia Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 85 Thailand Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 89 South Korea Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 94 Latin America Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 98 Brazil Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 102 Argentina Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MEA Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 MEA Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 107 MEA Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 108 MEA Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 111 South Africa Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 119 UAE Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global diagnostic reagents for infectious diseases market- Key market driver analysis
  • Fig. 7 Global diagnostic reagents for infectious diseases market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global diagnostic reagents for infectious diseases market - Porter's analysis
  • Fig. 10 Global diagnostic reagents for infectious diseases market - PESTEL analysis
  • Fig. 11 Global diagnostic reagents for infectious diseases market Product outlook key takeaways
  • Fig. 12 Global diagnostic reagents for infectious diseases market: Product movement analysis
  • Fig. 13 Molecular reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Immunoassay reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Rapid test reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Serology reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Controls and calibrators market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Global diagnostic reagents for infectious diseases market Disease area outlook key takeaways
  • Fig. 20 Global diagnostic reagents for infectious diseases market: Disease area movement analysis
  • Fig. 21 Respiratory infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Vector-borne & tropical diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Enteric infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Sexually transmitted infections (STIS) market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Other emerging / high-burden infectious diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Global diagnostic reagents for infectious diseases market: Technology outlook key takeaways
  • Fig. 27 Global diagnostic reagents for infectious diseases market: Technology movement analysis
  • Fig. 28 Molecular diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Immunoassays market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Point-of-care reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Multiplex platforms market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Global diagnostic reagents for infectious diseases market: End Use outlook key takeaways
  • Fig. 33 Global diagnostic reagents for infectious diseases market: End Use movement analysis
  • Fig. 34 Hospitals & clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Point-of-care / decentralized testing sites market estimates, 2021 - 2033 (USD Million)
  • Fig. 37 Public health agencies & national reference labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Academic & research institutes market estimates, 2021 - 2033 (USD Million)
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 Global diagnostic reagents for infectious diseases market: Regional movement analysis
  • Fig. 41 North America diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 46 UK diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 48 France diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 50 Italy diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 53 Norway diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 55 Japan diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 56 China diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 57 India diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 59 Australia diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 60 Thailand diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 64 MEA diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 69 Strategy framework